// App-Quantinova.ai

: 4Ra Blockade as a Treatment in Established H1N1 Infection in a Mouse Model of Allergic Asthma

Researchers

Presenter

  • K. Shahangian

Principal Investigators

  • R. Chen

  • D. A. Ngan

  • Y. Oh

  • D. A. Knight

  • D. R. Dorscheid

  • T. Hackett

  • K. M. McNagny

  • M. Niikura

  • P. Man

  • J. A. Hirota

  • D. D. Sin

Medical Centers

  • Centre for Heart Lung Innovation,Medicine, Vancouver BC, Canada

  • School of Biomedical Sciences & Pharmacy, University of Newcastle, Newcastle, NSW, Australia

  • Anesthesiology, Pharmacology & Therapeutics, UBC Centre for Heart Lung Innovation, St. Pauls Hospital, Vancouver, B.C., BC, Canada,

  • The University of British Columbia, Vancouver, BC, Canada

  • Health Sciences, Simon Fraser University, Vancouver, BC, Canada

  • McMaster University, Hamilton, ON, Canada

  • St Pauls Hospital, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Immunoglobulin G

  • Interleukin 4

  • Interleukin 5

  • Translocator protein

Drug/Treatment

  • IL-4

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved